Description

9-[(2-Chlorophenyl)Methyl]-4-Phenyl-8,10-Dihydropyrano[2,3-F][1,3]Benzoxazin-2-One is a high-purity, advanced pharmaceutical intermediate with a complex fused heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and process development.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the research and synthesis of new chemical entities (NCEs) for drug discovery programs.
• API Synthesis: Used in the development and scale-up of Active Pharmaceutical Ingredients, especially those with complex polycyclic frameworks.
• Medicinal Chemistry Research: Provides a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in academic and industrial R&D labs.
• Process Chemistry: Employed in route scouting and optimization for the efficient, scalable production of target drug molecules.
• Reference Standard: Can be supplied as a high-purity analytical standard for method development and quality control in pharmaceutical analysis.

Basic Information

Product Name	9-[(2-Chlorophenyl)Methyl]-4-Phenyl-8,10-Dihydropyrano[2,3-F][1,3]Benzoxazin-2-One
CAS No.	844656-06-0
Molecular Formula	C25H18ClNO3
Molecular Weight	415.87 g/mol
Synonyms	9-[(2-Chlorophenyl)methyl]-4-phenyl-8,10-dihydropyrano[2,3-f][1,3]benzoxazin-2-one; Pyrano[2,3-f][1,3]benzoxazin-2-one, 9-[(2-chlorophenyl)methyl]-4-phenyl-8,10-dihydro-; 844656-06-0; UNII-8J8P3099Q2; 8J8P3099Q2; SCHEMBL23306277; DTXSID60674469; BCP31033
EINECS	Contact for details

Quality Control

Our 9-[(2-Chlorophenyl)Methyl]-4-Phenyl-8,10-Dihydropyrano[2,3-F][1,3]Benzoxazin-2-One is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the stringent requirements for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.